Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Polycythemia Vera × durvalumab × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 27 Lung Neoplasms 12 Colorectal Neoplasms 11 Ovarian Neoplasms 10 Breast Neoplasms 10 Small Cell Lung Carcinoma 8 Urinary Bladder Neoplasms 7 Recurrence 6 Prostatic Neoplasms 6 Neoplasms 6 Head and Neck Neoplasms 6 Triple Negative Breast Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Pancreatic Neoplasms 5 Diabetes Mellitus, Insulin-Dependent, 12 5 Carcinoma, Hepatocellular 5 Carcinoma 5 Neoplasm Metastasis 4 Recurrent Squamous Cell Lung Carcinoma 3 Multiple Myeloma 3 Mouth Neoplasms 3 Mesothelioma 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, Follicular 3 Kidney Neoplasms 3 Esophageal Neoplasms 3 Cholangiocarcinoma 3 Carcinoma, Renal Cell 3 Uterine Cervical Neoplasms 2 Urothelial Cancer 2

Interventions

fludarabine phosphate 16 Whole-Body Irradiation 10 Peripheral Blood Stem Cell Transplantation 9 Mycophenolic Acid 9 ruxolitinib 8 Busulfan 8 Cyclophosphamide 7 Tacrolimus 6 fludarabine 5 Melphalan 5 Cyclosporine 5 Methotrexate 4 Antilymphocyte Serum 4 givinostat hydrochloride 3 givinostat 3 Lenalidomide 3 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3 thymoglobulin 2 pomalidomide 2 Surveys and Questionnaires 2 Stem Cell Transplantation 2 Prednisone 2 Hydroxyurea 2 Etoposide 2 Dasatinib 2 Carboplatin 2 veliparib 1 sonidegib 1 pembrolizumab 1 peginterferon alfa-2a 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡